High levels of CD2 expression identify HIV-1 latently infected resting memory CD4+ T cells in virally suppressed subjects.
about
Histone deacetylase inhibitor romidepsin induces HIV expression in CD4 T cells from patients on suppressive antiretroviral therapy at concentrations achieved by clinical dosing.HIVed, a knowledgebase for differentially expressed human genes and proteins during HIV infection, replication and latency.Myeloid dendritic cells induce HIV-1 latency in non-proliferating CD4+ T cells.Dynamics of HIV latency and reactivation in a primary CD4+ T cell model.Eradicating HIV-1 infection: seeking to clear a persistent pathogen.The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4(+) T-cells.Transcriptomic Analysis Implicates the p53 Signaling Pathway in the Establishment of HIV-1 Latency in Central Memory CD4 T Cells in an In Vitro Model.Paediatric HIV infection in the 'omics era: defining transcriptional signatures of viral control and vaccine responses.Can We Repurpose FDA-Approved Alefacept to Diminish the HIV Reservoir?Identification of glycoproteins associated with HIV latently infected cells using quantitative glycoproteomics.Expression of HIV-1 matrix protein p17 and association with B-cell lymphoma in HIV-1 transgenic mice.Kinase control of latent HIV-1 infection: PIM-1 kinase as a major contributor to HIV-1 reactivation.Experimental Approaches for Eliminating Latent HIV.Targeting HIV latency: resting memory T cells, hematopoietic progenitor cells and future directions.T cells with low CD2 levels express reduced restriction factors and are preferentially infected in therapy naïve chronic HIV-1 patients.Systems analysis of latent HIV reversal reveals altered stress kinase signaling and increased cell death in infected T cells.MicroRNA expression profiling of Xp11 renal cell carcinoma.CD32 Expression is not Associated to HIV-DNA content in CD4 cell subsets of individuals with Different Levels of HIV ControlMyeloid Dendritic Cells Induce HIV Latency in Proliferating CD4 T CellsEvidence That Combination Therapy With CD16-Bearing NK-92 Cells and FDA-Approved Alefacept Can Selectively Target the Latent HIV Reservoir in CD4+ CD2hi Memory T Cells
P2860
Q28537694-EBF2710E-58A9-4201-A452-C8213E6A5C0BQ30400491-05A3B154-B15D-4401-ACCB-055B5D825D32Q35067224-F12995D9-9130-410D-A07A-21C75FBE522FQ35176166-F1D83B91-F8F5-4A77-A99B-55E19F1ABD9BQ35252186-3E323CA9-1D3C-4F31-BBE8-81EF01912C81Q36053889-20A16E9D-3ECC-4170-AE75-CD4EFED36E71Q36206925-A47C5112-F95B-4DDF-ABF9-C928D48C3E58Q36487031-25D7922E-1154-4DBD-81E5-4082B4657180Q36827134-CE311B7B-A58E-4113-9A02-FFFF3ECF8DFEQ37383798-2A6DBE20-AA1E-41B4-A170-D172CAB04730Q37469500-4BD80C46-B832-463B-8D21-B856FA93B1CAQ37547710-65B4B215-5E63-419F-AACE-65A0717DE9D5Q37636531-1642AFF4-61CD-4344-969A-F1776B8DE47BQ38246141-D5AD8970-AB3D-4490-BDA6-62B1FDDE7FADQ41929461-4C517A4A-86D0-4FAE-96E7-86A8310BC444Q47096754-50B623FC-7CE8-4324-92C1-87B36ADBB95EQ50726690-0BF587BE-5522-45C2-93FE-F4780566C3F6Q57811386-087FA7D2-B310-498D-9DD1-4A8D5436BEEAQ58003754-F56B76C2-98FA-407D-B27B-3417A0FFE560Q59136962-76894F41-99D0-4AB6-89AF-FA7BB021856B
P2860
High levels of CD2 expression identify HIV-1 latently infected resting memory CD4+ T cells in virally suppressed subjects.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
High levels of CD2 expression ...... n virally suppressed subjects.
@en
High levels of CD2 expression ...... n virally suppressed subjects.
@nl
type
label
High levels of CD2 expression ...... n virally suppressed subjects.
@en
High levels of CD2 expression ...... n virally suppressed subjects.
@nl
prefLabel
High levels of CD2 expression ...... n virally suppressed subjects.
@en
High levels of CD2 expression ...... n virally suppressed subjects.
@nl
P2093
P2860
P356
P1433
P1476
High levels of CD2 expression ...... in virally suppressed subjects
@en
P2093
Claire Vandergeeten
Fabio Romerio
Maria Iglesias-Ussel
P2860
P304
P356
10.1128/JVI.01297-13
P407
P577
2013-06-12T00:00:00Z